|
| Click above to purchase the entire issue for only $30.00! |
| Article Cost: $10.00 |
 |
|
| Briefings on Infection Control |
| June 2008 |
| Strategies to prevent the spread of vancomycin-resistant enterococci in your facility |
| Vancomycin-resistant enterococci (VRE) spends far less time in the spotlight than MDROs, particularly MRSA. Although this organism may be less pathogenic than some of its more famous counterparts, it still poses a serious concern for healthcare facilities.
Not only does VRE cause complications for already sick patients, resulting in longer stays and higher costs, but there is another concern-chiefly that it will meet with MRSA in a co-colonized patient and mutate, spreading vancomycin-resistant Staphylococcus aureus (VRSA), says Connie Steed, RN, BSN, CIC, manager of IC at the Greenville (SC) Hospital System. |
| Briefings on Infection Control subscribers, please sign on for access |
|
